0 Articles
0 News
0 Properties
0 Page
0 Blog

Fujifilm Diosynth Biotechnologies

Made in the Brazos Valley

The core purpose of Fujifilm Diosynth Biotechnologies Texas (FDBT) is “Partners for Life, Advancing Tomorrow’s Medicines.” Fujifilm partners with its customers to advance their medicines, with its staff by offering them opportunities to progress their careers, with regulatory agencies to ensure a safe and effective product, and with the Brazos Valley community.
The company is driven by its core values: trust, delighting customers, Gemba and Genki. Gemba is the Japanese principle of direct observation. If you want to learn something, go see it directly. Genki is the Japanese principle of enthusiasm and passion.
FDBT is a biopharmaceutical contract development and manufacturing organization (CDMO) helping companies progress their medicines by offering development and manufacturing services. In short, they develop and manufacture biologics and gene therapies for biopharmaceutical companies. Their products are developed for organizations around the globe.
FDBT began operations in the Brazos Valley in 2014 after it acquired Kalon Biotherapeutics, a biopharmaceutical CMO founded by the Texas A&M University System in 2011. This particular facility located in the Biocorridor in College Station offered manufacturing capabilities not found at the company’s other sites in North Carolina and the United Kingdom. Additionally, the College Station site provided the opportunity to partner with the Texas A&M University System and the Biomedical Advanced Research and Development Authority (BARDA), a department of the US Government on the manufacture of vaccines and medical counter measure products.
The Brazos Valley location currently employs 180 people with plans to grow to over 200 by the end of 2019. Fujifilm hired 70 new staff members in 2018 alone. With a technology-driven business, Fujifilm requires technically-trained staff. The company employs scientists, virologists, chemical engineers, process engineers, automation engineers, quality control, quality assurance and GMP-trained manufacturing technicians.
Fujifilm has grown tremendously in the last five years. The Fujifilm Corporation has been committed to grow Fujifilm Diosynth Biotechnologies through significant investments, many of which have been allocated to the Brazos Valley site. Some of the investments made in 2017 focused on their high throughput monoclonal antibody facility. In 2018, it extended to their gene therapy facility and included adding new services in the area of Final Drug Product production. Here in College Station, the antibody and late stage gene therapy manufacturing facilities came on line in 2018 with the production of material for Phase 1 and Phase III clinical trials.
Dr. Gerry Farrell, Chief Operating Officer of the College Station site, shared what he perceived to be the advantages of doing business in the Brazos Valley:
“We have Texas A&M University and Blinn College on our doorstep who are producing our next crop of technicians, scientists and engineers, and another 12 major universities within a two-hour drive. We appreciate the support and welcome we have received from the City of Bryan, the City of College Station and the county facilitated by the Brazos Valley Economic Development Corporation. We are very much invested in the community. We have strong local connections with these various groups and our relationship with Texas A&M is strong.”
FDBT develops and manufactures medicines that have a profound impact on people’s lives, and that is what fuels the passion that drives each and every one of its employees.
For more information on Fujifilm Diosynth Biotechnologies, visit their website, fujifilmdiosynth.com.
Feature from February 2019